Serum YKL-40 Levels Declined in Properly Treated Asthma Patients
Chitinase-like protein YKL-40 serum levels decreased in patients with asthma after they received appropriate inhaled corticosteroid therapy, according to recent study results.
Chitinase-like protein YKL-40 serum levels decreased in patients with asthma after they received appropriate inhaled corticosteroid therapy, according to recent study results.
Scientists have discovered a brain protein that speeds an animal's recovery during the flu.
The final rule sets forth criteria for submitting claims to Medicare for CCM services and establishes a base reimbursement rate of $42.60 for such services.
Clinicians should prescribe antivirals for hospitalized, severely ill, and high-risk patients with flu symptoms without waiting for lab confirmation of the virus.
Read MoreCommunity pharmacists’ support of COPD patients is cost effective and can improve adherence, according to research published in the International Journal of Pharmacy Practice.
Read Moreospital-level factors including hospital volume, academic affiliation and presence of a mobility protocol were associated with report of higher level activity and delivery of activity to high severity patients.
Read MoreElectronic cigarettes should be subject to the same taxes, marketing restrictions and limitations on public use as traditional tobacco products, experts say.
Read MoreIn a new study, patients with obstructive sleep apnea who wore compression stockings during the day for two weeks saw their frequency of apneas decrease by 27%.
Read MoreBabies who gain weight rapidly in the first three months of life are more likely to develop asthma and have it persist into adolescence, according to University of Bristol research.
Read MoreResearchers who analyzed US hospitalization data and found a connection between RSV and the risk of pneumonia caused by S. pneumoniae.
Read MoreExperts warn that the US healthcare system is in danger of a shortage of resources as Medicare coverage of lung cancer CT screening for at-risk beneficiaries goes into effect this year.
Read MoreIowa will begin requiring all hospitals in the state to screen newborns for congenital heart defects using pulse oximetry.
Read MoreCapnia,Inc, has announced that it has submitted an application to the FDA to request Orphan Drug Designation for its nasal technology that treats trigeminal neuralgia.
Read MoreProtalix BioTherapeutics Inc has announced a new strategy for company growth.
Read MoreValeant Pharmaceuticals has recalled its antiviral drug Virazole, used to treat hospitalized infants and young children with severe lower respiratory tract infections due to RSV.
Read More